Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop.

Hughes KS, Ambinder EP, Hess GP, Yu PP, Bernstam EV, Routbort MJ, Clemenceau JR, Hamm JT, Febbo PG, Domchek SM, Chen JL, Warner JL; OPO Workshop Members.

J Clin Oncol. 2017 Sep 20;35(27):3153-3159. doi: 10.1200/JCO.2017.74.1744. Epub 2017 Jul 24.

PMID:
28737972
2.

R.A.P.I.D. (Root Aggregated Prioritized Information Display): A single screen display for efficient digital triaging of medical reports.

Ford JP, Huang L, Richards DS, Ambinder EP, Rosenberger JL.

J Biomed Inform. 2016 Jun;61:214-23. doi: 10.1016/j.jbi.2016.04.001. Epub 2016 Apr 5.

3.

Data Sharing to Support the Cancer Journey in the Digital Era.

Krauss JC, Warner JL, Maddux SE, Brown JR, Moldwin R, Schorer AE, Hughes KS, Ambinder EP.

J Oncol Pract. 2016 Mar;12(3):201-7. doi: 10.1200/JOP.2015.007740. Epub 2016 Jan 12. No abstract available.

PMID:
26759494
4.

Development, implementation, and initial evaluation of a foundational open interoperability standard for oncology treatment planning and summarization.

Warner JL, Maddux SE, Hughes KS, Krauss JC, Yu PP, Shulman LN, Mayer DK, Hogarth M, Shafarman M, Stover Fiscalini A, Esserman L, Alschuler L, Koromia GA, Gonzaga Z, Ambinder EP.

J Am Med Inform Assoc. 2015 May;22(3):577-86. doi: 10.1093/jamia/ocu015. Epub 2015 Jan 20.

PMID:
25604811
5.

Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum.

Bartley AN, Hamilton SR, Alsabeh R, Ambinder EP, Berman M, Collins E, Fitzgibbons PL, Gress DM, Nowak JA, Samowitz WS, Zafar SY; Members of the Cancer Biomarker Reporting Workgroup, College of American Pathologists.

Arch Pathol Lab Med. 2014 Feb;138(2):166-70. doi: 10.5858/arpa.2013-0231-CP. Epub 2013 Jun 28. No abstract available.

PMID:
23808403
6.

The information age, cyberspace, and cancer.

Ambinder EP.

Oncology (Williston Park). 2012 Apr;26(4):324, 326-7. No abstract available.

7.

Principles of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 2 of 2.

Shulman LN, Miller RS, Ambinder EP, Yu PP, Cox JV.

J Oncol Pract. 2008 Sep;4(5):254-257. doi: 10.1200/JOP.0857501.

8.

Principles of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 1 of 2.

Shulman LN, Miller RS, Ambinder EP, Yu PP, Cox JV.

J Oncol Pract. 2008 Jul;4(4):203-206. doi: 10.1200/JOP.0847501.

9.

Advancing high-quality cancer care: cancer biomedical informatics grid supports personalized medicine and the electronic health record.

Whippen D, Deering MJ, Ambinder EP.

J Oncol Pract. 2007 Jul;3(4):208-11. doi: 10.1200/JOP.0743501. No abstract available.

10.

ASCO's Role in Facilitating the Adoption of Electronic Records in Oncology.

Ambinder EP.

J Oncol Pract. 2005 Jul;1(2):64-5. No abstract available.

11.

Electronic health records.

Ambinder EP.

J Oncol Pract. 2005 Jul;1(2):57-63. No abstract available.

12.

A history of the shift toward full computerization of medicine.

Ambinder EP.

J Oncol Pract. 2005 Jul;1(2):54-6. No abstract available.

13.

Jumping translocations in leukemia.

Najfeld V, Hauschildt B, Scalise A, Gattani A, Patel R, Ambinder EP, Silverman LR.

Leukemia. 1995 Apr;9(4):634-9.

PMID:
7723397
14.

Myelodysplastic syndrome transforming to acute promyelocytic-like leukemia with trisomy and rearrangement of chromosome 11.

Najfeld V, Chen A, Scalise A, Ambinder EP, Fernandez G, Waxman S.

Genes Chromosomes Cancer. 1994 May;10(1):15-25.

PMID:
7519869
15.

Hemochromatosis and hepatitis C.

Jaffin BW, Ambinder EP.

Hosp Pract (Off Ed). 1991 Apr;26 Suppl 3:50-1. No abstract available.

PMID:
1901317
16.

Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients.

Richner J, Ambinder EP, Hoffmann K, Feuer EJ, Bekesi G.

Cancer Immunol Immunother. 1991;34(2):138-42.

PMID:
1684737
17.

Iatrogenic and idiopathic acute myelogenous leukemia: a comparison of clinical features and treatment complications.

Williams CK, Cuttner J, Ohnuma T, Ambinder EP, Ferreira PP, Holland JF.

Med Oncol Tumor Pharmacother. 1987;4(2):59-66.

PMID:
3478544
18.

Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.

Cohen SM, Ohnuma T, Ambinder EP, Holland JF.

Cancer Treat Rep. 1986 May;70(5):688-9. No abstract available.

PMID:
2423239
19.

Azathioprine experience in severe, generalized, recalcitrant myasthenia gravis.

Kornfeld P, Ambinder EP, Matta R, Bender A, Papatestas AE, Gross H, Genkins G.

Mt Sinai J Med. 1985 May;52(5):347-52. No abstract available.

PMID:
3874354
20.

Role of plasmapheresis in primary biliary cirrhosis.

Cohen LB, Ambinder EP, Wolke AM, Field SP, Schaffner F.

Gut. 1985 Mar;26(3):291-4.

21.

Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.

Sridhar KS, Ohnuma T, Biller H, Holland JF, Ambinder EP, Barba J.

Am J Clin Oncol. 1985 Feb;8(1):55-60.

PMID:
2581436
22.

The clinical effectiveness and safety of chronic plasmapheresis in patients with primary biliary cirrhosis.

Ambinder EP, Cohen LB, Wolke AM, Field SP, Adelsberg B, Schaffner F, Zaroulis CG.

J Clin Apher. 1985;2(3):219-23.

PMID:
4030709
23.

Extraskeletal Ewing sarcoma with computed tomography correlation.

Rose JS, Hermann G, Mendelson DS, Ambinder EP.

Skeletal Radiol. 1983;9(4):234-7.

PMID:
6867772
24.

Role of opsonins in clinical response to granulocyte transfusion in granulocytopenic patients.

Keusch GT, Ambinder EP, Kovacs I, Goldberg JD, Phillips DM, Holland JF.

Am J Med. 1982 Oct;73(4):552-63.

PMID:
6751084
25.

Therapeutic leukapheresis in a patient with hairy cell leukemia presenting with a white cell count greater than 500,000 /microliter.

Worsley A, Cuttner J, Gordon R, Reilly M, Ambinder EP, Conjalka M.

Transfusion. 1982 Jul-Aug;22(4):308-10.

PMID:
7101424
26.

Acetylcholine receptor antibodies in myasthenia gravis.

Kornfeld P, Nall J, Smith H, Mittag TW, Bender AN, Ambinder EP, Horowitz SH, Papatestas AE, Gross H, Genkins G.

Muscle Nerve. 1981 Sep-Oct;4(5):413-9.

PMID:
6974823
27.

Plasmapheresis in refractory generalized myasthenia gravis.

Kornfeld P, Ambinder EP, Mittag T, Bender AN, Papatestas AE, Goldberg J, Genkins G.

Arch Neurol. 1981 Aug;38(8):478-81.

PMID:
7247783
28.

Filtration versus gravity leukapheresis in febrile granulocytopenic patients: a randomized prospective trial.

Ambinder EP, Button GR, Cheung T, Goldberg JD, Holland JF.

Blood. 1981 May;57(5):836-41.

PMID:
6938259
29.

Plasmapheresis in myasthenia gravis: controlled study.

Kornfeld P, Ambinder EP, Papatestas AE, Bender AN, Genkins G.

Lancet. 1979 Sep 22;2(8143):629. No abstract available.

PMID:
90282
30.

High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer.

Ambinder EP, Perloff M, Ohnuma T, Biller HF, Holland JF.

Cancer. 1979 Apr;43(4):1177-82.

PMID:
312690
31.

Therapeutic leukopheresis of acute myelo-monocytic leukemia in pregnancy.

Meyer RJ, Cuttner J, Truog P, Ambinder EP, Holland JF.

Med Pediatr Oncol. 1978;4(1):77-83.

PMID:
272483
32.

Prolongation of survival of skin homografts in mice with cinanserin alone and in combination with azathioprine.

Ambinder EP, Schwartz GH, Rubin AL, Stenzel KH.

Transplantation. 1969 Feb;7(2):147-9. No abstract available.

PMID:
4884917

Supplemental Content

Loading ...
Support Center